Literature DB >> 22502901

Therapeutic ranges of serum digoxin concentrations in patients with heart failure.

Zachary D Goldberger, Ary L Goldberger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22502901      PMCID： PMC3646412          DOI： 10.1016/j.amjcard.2012.02.028

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  39 in total

Review 1.  Why don't physicians follow clinical practice guidelines? A framework for improvement.

Authors:  M D Cabana; C S Rand; N R Powe; A W Wu; M H Wilson; P A Abboud; H R Rubin
Journal:  JAMA       Date:  1999-10-20       Impact factor: 56.272

Review 2.  Clinical inertia.

Authors:  L S Phillips; W T Branch; C B Cook; J P Doyle; I M El-Kebbi; D L Gallina; C D Miller; D C Ziemer; C S Barnes
Journal:  Ann Intern Med       Date:  2001-11-06       Impact factor: 25.391

Review 3.  Lower serum digoxin concentrations in heart failure and reassessment of laboratory report forms.

Authors:  Roya M Sameri; Judith E Soberman; Christopher K Finch; Timothy H Self
Journal:  Am J Med Sci       Date:  2002-07       Impact factor: 2.378

4.  Emergency hospitalizations for adverse drug events in older Americans.

Authors:  Daniel S Budnitz; Maribeth C Lovegrove; Nadine Shehab; Chesley L Richards
Journal:  N Engl J Med       Date:  2011-11-24       Impact factor: 91.245

5.  Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.

Authors:  M D Flather; S Yusuf; L Køber; M Pfeffer; A Hall; G Murray; C Torp-Pedersen; S Ball; J Pogue; L Moyé; E Braunwald
Journal:  Lancet       Date:  2000-05-06       Impact factor: 79.321

6.  Sex-based differences in the effect of digoxin for the treatment of heart failure.

Authors:  Saif S Rathore; Yongfei Wang; Harlan M Krumholz
Journal:  N Engl J Med       Date:  2002-10-31       Impact factor: 91.245

Review 7.  Potentially significant drug interactions of class III antiarrhythmic drugs.

Authors:  Weeranuj Yamreudeewong; Michael DeBisschop; Linda G Martin; Dennis L Lower
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

8.  Association of serum digoxin concentration and outcomes in patients with heart failure.

Authors:  Saif S Rathore; Jeptha P Curtis; Yongfei Wang; Michael R Bristow; Harlan M Krumholz
Journal:  JAMA       Date:  2003-02-19       Impact factor: 56.272

9.  Beta-blockers in congestive heart failure. A Bayesian meta-analysis.

Authors:  J M Brophy; L Joseph; J L Rouleau
Journal:  Ann Intern Med       Date:  2001-04-03       Impact factor: 25.391

Review 10.  Amiodarone: guidelines for use and monitoring.

Authors:  Lyle A Siddoway
Journal:  Am Fam Physician       Date:  2003-12-01       Impact factor: 3.292
View more
  18 in total

1.  Digoxin toxicity: Case for retiring its use in elderly patients?

Authors:  Nora MacLeod-Glover; Matthew Mink; Mark Yarema; Ryan Chuang
Journal:  Can Fam Physician       Date:  2016-03       Impact factor: 3.275

Review 2.  Contemporary Controversies in Digoxin Use in Systolic Heart Failure.

Authors:  Chonyang L Albert; Forum Kamdar; Mazen Hanna
Journal:  Curr Heart Fail Rep       Date:  2016-10

3.  Emergency department visits and hospitalizations for digoxin toxicity: United States, 2005 to 2010.

Authors:  Isaac See; Nadine Shehab; Scott R Kegler; S Raja Laskar; Daniel S Budnitz
Journal:  Circ Heart Fail       Date:  2013-12-03       Impact factor: 8.790

4.  Identification of Na+/K+-ATPase inhibition-independent proarrhythmic ionic mechanisms of cardiac glycosides.

Authors:  Cai Hong Koh; Jianjun Wu; Ying Ying Chung; Zhenfeng Liu; Rong-Rong Zhang; Ketpin Chong; Vladimir Korzh; Sherwin Ting; Steve Oh; Winston Shim; Hai-Yan Tian; Heming Wei
Journal:  Sci Rep       Date:  2017-05-26       Impact factor: 4.379

5.  Drug discovery with an RBM20 dependent titin splice reporter identifies cardenolides as lead structures to improve cardiac filling.

Authors:  Martin Liss; Michael H Radke; Jamina Eckhard; Martin Neuenschwander; Vita Dauksaite; Jens-Peter von Kries; Michael Gotthardt
Journal:  PLoS One       Date:  2018-06-11       Impact factor: 3.240

6.  Improvement of Adequate Digoxin Dosage: An Application of Machine Learning Approach.

Authors:  Ya-Han Hu; Chun-Tien Tai; Chih-Fong Tsai; Min-Wei Huang
Journal:  J Healthc Eng       Date:  2018-08-19       Impact factor: 2.682

7.  Chronic digitalis therapy in patients before heart transplantation is an independent risk factor for increased posttransplant mortality.

Authors:  Rasmus Rivinius; Matthias Helmschrott; Arjang Ruhparwar; Ann-Kathrin Rahm; Fabrice F Darche; Dierk Thomas; Tom Bruckner; Philipp Ehlermann; Hugo A Katus; Andreas O Doesch
Journal:  Ther Clin Risk Manag       Date:  2017-10-13       Impact factor: 2.423

Review 8.  Therapy-Induced Senescence: An "Old" Friend Becomes the Enemy.

Authors:  Tareq Saleh; Sarah Bloukh; Valerie J Carpenter; Enas Alwohoush; Jomana Bakeer; Sarah Darwish; Belal Azab; David A Gewirtz
Journal:  Cancers (Basel)       Date:  2020-03-29       Impact factor: 6.639

9.  Therapeutic Drug Monitoring Characteristics in a Tertiary University Hospital in 2019.

Authors:  Zeynep Günes Ozunal; Belkiz Ongen İpek
Journal:  Cureus       Date:  2020-04-10

10.  Predicting the serum digoxin concentrations of infants in the neonatal intensive care unit through an artificial neural network.

Authors:  Shu-Hui Yao; Hsiang-Te Tsai; Wen-Lin Lin; Yu-Chieh Chen; Chiahung Chou; Hsiang-Wen Lin
Journal:  BMC Pediatr       Date:  2019-12-27       Impact factor: 2.125
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.